Menu
Recruiting NCT07068789

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

No phase Interventional Chronic Limb Threatening Ischemia Infrapopliteal Arterial Occlusive Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: balloon angioplasty.
Who it may be relevant to
Registry conditions: Chronic Limb Threatening Ischemia, Infrapopliteal Arterial Occlusive Disease. Basic parameters: from 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Revascularization of Single Versus Multiple Infrapopliteal Vesseles in Chronic Limb Threatening Ischemia : Limb Salvage Rate

Overview

This interventional prospective study aims to assess the effectiveness of single vessel versus multiple vessel infrapopliteal angioplasty in patients with chronic threatening limb ischemia . The study compares limb salvage rates and clinical outcomes across two groups over a defined follow up period

Interventions

  • Procedure balloon angioplasty
    endovascular angioplasty of infrapopliteal arteries performed using standard balloon catheters under fluroscopic guidance to restore blood flow to the ischemic area

Primary outcome measures

  • limb salvage rate [Time frame: 6 months ( with optional follow up at 12 months )]
  • limb salvage rate [Time frame: 6 months ( with optional follow up at 12 months )]

Eligibility criteria

Inclusion Criteria: 1. patients aged 40 years or older 2. patients with Rutherford category "4" and "5" 3. patients with angiographic evidence of infrapopliteal vessel occlusive disease -

Exclusion criteria

  • patients who refuse to participate in the study
  • patients with isolated proximal arterial disease (e.g SFA or popliteal ) without infrapopliteal involvement
  • patients who develop acute thrombosis , flow limiting dissection or perforation in the infrapopliteal arteries during intervention -

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Faculty of Medicine of Sohag — Sohag

Identifiers

NCT: NCT07068789 · Soh-Med-25-6-14MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗